PolyPeptide Group AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	389.33	336.79	320.37	280.98	282.13
Revenue	389.33	336.79	320.37	280.98	282.13
Revenue Growth (YoY)	15.60%	5.13%	14.02%	-0.41%	25.78%
Cost of Revenue	324.04	299.31	315.6	228.99	182.43
Gross Profit	65.29	37.49	4.77	51.99	99.7
Selling, General & Admin	55.64	44.25	41.54	40.63	32.5
Research & Development	2.28	1.1	1.47	1.24	1.41
Other Operating Expenses	-1.11	-1.9	-4.4	-2.41	-1.61
Operating Expenses	56.82	43.44	38.6	39.46	32.3
Operating Income	8.47	-5.95	-33.83	12.53	67.4
Interest Expense	-17.2	-13.85	-5.62	-2.09	-2.82
Interest & Investment Income	1.82	0.59	0.05	0.01	0.01
Currency Exchange Gain (Loss)	-12.27	6.18	-14.5	-1.63	-1.87
Other Non Operating Income (Expenses)	-1.02	-3.63	-1.63	-1.25	-0.17
EBT Excluding Unusual Items	-20.2	-16.66	-55.52	7.57	62.55
Gain (Loss) on Sale of Assets	1.44	-	-	-	-
Asset Writedown	-1.3	-1.49	-2.72	-	-
Other Unusual Items	-	-	-	-	-2.71
Pretax Income	-20.06	-18.15	-58.24	7.57	59.85
Income Tax Expense	1.11	1.42	-6.8	-0.2	12.59
Net Income	-21.17	-19.56	-51.44	7.77	47.26
Net Income to Common	-21.17	-19.56	-51.44	7.77	47.26
Net Income Growth	-	-	-	-83.56%	50.81%
Shares Outstanding (Basic)	33	33	33	33	32
Shares Outstanding (Diluted)	33	33	33	33	32
Shares Change (YoY)	0.09%	0.10%	-0.11%	2.74%	7.08%
EPS (Basic)	-0.64	-0.59	-1.56	0.24	1.47
EPS (Diluted)	-0.64	-0.59	-1.56	0.24	1.47
EPS Growth	-	-	-	-83.98%	41.35%
Free Cash Flow	-30.24	3.65	-16.41	-69.64	-16.61
Free Cash Flow Per Share	-0.92	0.11	-0.50	-2.11	-0.52
Dividend Per Share	-	-	-	-	0.289
Gross Margin	16.77%	11.13%	1.49%	18.50%	35.34%
Operating Margin	2.18%	-1.77%	-10.56%	4.46%	23.89%
Profit Margin	-5.44%	-5.81%	-16.06%	2.76%	16.75%
Free Cash Flow Margin	-7.77%	1.08%	-5.12%	-24.79%	-5.89%
EBITDA	38.1	18.28	-12.31	33.05	83.46
EBITDA Margin	9.79%	5.43%	-3.84%	11.76%	29.58%
D&A For EBITDA	29.63	24.23	21.52	20.53	16.06
EBIT	8.47	-5.95	-33.83	12.53	67.4
EBIT Margin	2.18%	-1.77%	-10.56%	4.46%	23.89%
Effective Tax Rate	-	-	-	-	21.04%
Revenue as Reported	391.95	338.77	324.85	283.46	286.22

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.